BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28768662)

  • 21. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.
    Wise LE; Long KA; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
    ACS Chem Neurosci; 2012 May; 3(5):369-78. PubMed ID: 22860205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocannabinoid regulation in human endometrium across the menstrual cycle.
    Scotchie JG; Savaris RF; Martin CE; Young SL
    Reprod Sci; 2015 Jan; 22(1):113-23. PubMed ID: 24819878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of blood endocannabinoids during anaesthesia: a special case for fatty acid amide hydrolase inhibition by propofol?
    Jarzimski C; Karst M; Zoerner AA; Rakers C; May M; Suchy MT; Tsikas D; Krauss JK; Scheinichen D; Jordan J; Engeli S
    Br J Clin Pharmacol; 2012 Jul; 74(1):54-9. PubMed ID: 22242687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S; Ayyannan SR
    ChemMedChem; 2021 Jul; 16(14):2172-2187. PubMed ID: 33834617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
    Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.
    Day TA; Rakhshan F; Deutsch DG; Barker EL
    Mol Pharmacol; 2001 Jun; 59(6):1369-75. PubMed ID: 11353795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro.
    Vandevoorde S; Jonsson KO; Labar G; Persson E; Lambert DM; Fowler CJ
    Br J Pharmacol; 2007 Jan; 150(2):186-91. PubMed ID: 17143303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
    Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
    Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
    Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
    Clapper JR; Moreno-Sanz G; Russo R; Guijarro A; Vacondio F; Duranti A; Tontini A; Sanchini S; Sciolino NR; Spradley JM; Hohmann AG; Calignano A; Mor M; Tarzia G; Piomelli D
    Nat Neurosci; 2010 Oct; 13(10):1265-70. PubMed ID: 20852626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of endocannabinoid system and cyclooxygenase metabolites with fatty acid amide hydrolase and cyclooxygenase enzyme activities on contractile responses in rat vas deferens tissue.
    Vural EH; Ozturk Fincan GS; Okcay Y; Askin CI; Gudul Bacanli M; Vural IM
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4123-4137. PubMed ID: 38032490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations.
    Siegmund SV; Wojtalla A; Schlosser M; Zimmer A; Singer MV
    Biochem Biophys Res Commun; 2013 Jul; 437(1):48-54. PubMed ID: 23806692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A; Saario S; Nevalainen T
    Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
    Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):263-272. PubMed ID: 31522241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocannabinoid Catabolic Enzymes Play Differential Roles in Thermal Homeostasis in Response to Environmental or Immune Challenge.
    Nass SR; Long JZ; Schlosburg JE; Cravatt BF; Lichtman AH; Kinsey SG
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):364-70. PubMed ID: 25715681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis.
    Pulgar VM; Yamaleyeva LM; Varagic J; McGee CM; Bader M; Dechend R; Howlett AC; Brosnihan KB
    Hypertension; 2014 Sep; 64(3):619-25. PubMed ID: 24935942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological evaluation of pyridone alkaloids on the endocannabinoid system.
    Chicca A; Berg R; Jessen HJ; Marck N; Schmid F; Burch P; Gertsch J; Gademann K
    Bioorg Med Chem; 2017 Nov; 25(22):6102-6114. PubMed ID: 28284861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
    Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ
    Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.